Metraipolis › archive › dc_44d09e9fa0c4

Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients — Europe PMC PPR:PPR227164

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR227164
DOI
10.1101/2020.10.15.341479
License (as archived)
CC0-1.0
Archived
2026-11-07T05:20:52.097Z
SHA-256 of the archived text
c00f8a1538a5ce33f7a52f2a92872c6e0cfd5ebff4f7a7796c61822d63308f77
Stable URL of this page
https://metraipolis.com/documento/dc_44d09e9fa0c4

How to cite

Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients — Europe PMC PPR:PPR227164 — Europe PMC, https://europepmc.org/article/PPR/PPR227164 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_44d09e9fa0c4 (Metraipolis archive dc_44d09e9fa0c4, sha256 c00f8a1538a5ce33f7a52f2a92872c6e0cfd5ebff4f7a7796c61822d63308f77)
BibTeX
@misc{dc44d09e9fa0c4,
  title = {Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients — Europe PMC PPR:PPR227164},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR227164},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_44d09e9fa0c4; sha256 c00f8a1538a5ce33f7a52f2a92872c6e0cfd5ebff4f7a7796c61822d63308f77},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR227164. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

SARS-CoV-2 is a deadly virus that is causing the global pandemic coronavirus disease 2019 (COVID-19). Our immune system plays a critical role in preventing, clearing, and treating the virus, but aberrant immune responses can contribute to deleterious symptoms and mortality. Many aspects of immune responses to SARS-CoV-2 are being investigated, but little is known about immune responses to carbohydrates. Since the surface of the virus is heavily glycosylated, pre-existing antibodies to glycans could potentially recognize the virus and influence disease progression. Furthermore, antibody responses to carbohydrates could be induced, affecting disease severity and clinical outcome. In this study, we used a carbohydrate antigen microarray with over 800 individual components to profile serum anti-glycan antibodies in COVID-19 patients and healthy control subjects. In COVID-19 patients, we observed abnormally high IgG and IgM antibodies to numerous self-glycans, including gangliosides, N -linked glycans, LacNAc-containing glycans, blood group H, and sialyl Lewis X. Some of these anti-glycan antibodies are known to play roles in autoimmune diseases and neurological disorders, which may help explain some of the unusual and prolonged symptoms observed in COVID-19 patients. The detection of antibodies to self-glycans has important implications for using convalescent serum to treat patients, developing safe and effective SARS-CoV-2 vaccines, and understanding the risks of infection. In addition, this study provides new insight into the immune responses to SARS-CoV-2 and illustrates the importance of including host and viral carbohydrate antigens when studying immune responses to viruses.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: bioRxiv, 2020 (prima pubblicazione 2020-10-16).
Identificativi: DOI 10.1101/2020.10.15.341479.
Pagina: https://europepmc.org/article/PPR/PPR227164 — https://doi.org/10.1101/2020.10.15.341479. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-07T05:19:00.412Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.